Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1248 of 5804
-
A handheld device that vibrates the airways may help COPD patients breathe easier
Symptom relief CompletedThe goal of this non-pharmacologic interventional study is to learn if Oscillatory Positive Expiratory Pressure (OPEP) therapy can improve disease impact and respiratory system dynamics in patients with COPD. The main questions it aims to answer are: Is OPEP therapy able to impr…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
Friendly bacteria gel could tame eczema flares
Disease control Recruiting nowThis is a Phase 1b, randomized, placebo/vehicle-controlled, double-blinded, multi-center trial. It is designed to assess the safety and efficacy of S. hominis A9 (ShA9) topical application as a treatment for atopic dermatitis (AD). The trial will enroll adults and pediatric parti…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Phlegm test could finally silence chronic cough in lung patients
Symptom relief Recruiting nowIn Interstitial Lung Disease (ILD) there is thickening of lung tissue, which makes it difficult for patients to breathe and get enough oxygen into their bodies. In addition to shortness of breath, daily cough is very common, with 4 out of 5 patients experiencing this symptom. Cou…
Phase: NA • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Engineered immune cells take on Hard-to-Treat cancers
Disease control Recruiting nowThis study was a phase I safety and tolerability clinical trial conducted in a single-center, open-label, 3+3 design with dose escalation.
Phase: PHASE1 • Sponsor: Guangzhou FineImmune Biotechnology Co., LTD. • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC
-
New drug teclistamab tested for safety in Tough-to-Treat blood cancer
Disease control Recruiting nowThe purpose of this study is to assess the safety of teclistamab in routine clinical practice when given as monotherapy in Indian participants with relapsed and refractory multiple myeloma (RRMM) (that is, a blood cancer that comes back after treatment or does not respond to trea…
Phase: PHASE4 • Sponsor: Johnson & Johnson Private Limited • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug cocktail HRS-6209 shows promise in early breast cancer trial
Disease control Recruiting nowThis is a study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HRS-6209 combined with other treatment regimens in breast cancer patients, and preliminarily observe its anti-tumor efficacy.
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common hand condition reveal hidden heart disease? new imaging trial investigates
Diagnosis ENROLLING_BY_INVITATIONThis clinical trial will use the amyloid-binding radiotracer, 124I-evuzamitide, to potentially detect amyloid, in the heart and elsewhere, in patients who have a history of lumbar spinal stenosis and/or carpal tunnel syndrome.
Phase: PHASE2 • Sponsor: University of Tennessee Graduate School of Medicine • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
New pill aims to fight excessive daytime sleepiness
Symptom relief Recruiting nowThe purpose of this study is to measure the safety and decrease in daytime sleepiness in subjects with Idiopathic Hypersomnia when taking ALKS 2680 tablets compared with placebo tablets
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New trial aims to standardize heart valve repair for common birth defect
Disease control Recruiting nowBackground: Between one-third and one-half of patients with bicuspid aortic valve (BAV) disease develop significant aortic regurgitation (AR) at a young age, leading to cardiomyopathy and heart failure. Aortic valve repair is an evolving and still underused strategy in BAV patien…
Phase: NA • Sponsor: University Hospital Augsburg • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Engineered immune cells take on recurrent brain tumors in early trial
Disease control Recruiting nowThis phase I trial tests the safety, side effects, and best dose of anti-glycoprotein-A repetitions predominant (GARP) chimeric antigen receptor (CAR) T cell therapy and how well it works in treating patients with grade III or IV gliomas that have come back after a period of impr…
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New study tracks Real-World impact of hemophilia drug on joint health
Disease control Recruiting nowThe rationale for this study is to further understand and describe the long-term prophylactic effectiveness of efanesoctocog alfa in preventing joint bleeds in a real-life setting.
Phase: PHASE4 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Fat cells to the rescue? new treatment for arthritic knees enters human testing
Disease control Recruiting nowThis study is being conducted to evaluate the safety and tolerability of OA-SYS in patients with moderate to severe OA of the knee joint.
Phase: PHASE2 • Sponsor: Ageless Biotech, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:55 UTC
-
Mini stent offers hope for babies with blocked heart arteries
Disease control Recruiting nowThis Post-Approval Study is a single arm, prospective, multi-center, open-label study of patients treated with the Renata Minima Stent System in the United States. The objective of the study is to continue the assessment of device performance and capture outcome data on use of th…
Sponsor: Renata Medical • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New asthma drug verekitug tested for Long-Term safety
Disease control OngoingThe primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT study (NCT06196879).
Phase: PHASE2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to boost esophageal cancer survival
Disease control Recruiting nowRationale: Esophageal cancer (EC) is the seventh most frequently diagnosed cancer and the sixth leading cause of cancer-related death worldwide. As a result of the late onset of symptoms, most patients with EC present in an advanced stage with a corresponding poor prognosis. Poor…
Phase: PHASE1 • Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Simple blood test could predict stomach cancer risk
Knowledge-focused Recruiting nowInvestigator propose the implementation of circulating biomarker monitoring, focusing on molecules related to the progression of gastric atrophy and/or associated with gastric cancer. Monitoring these biomarkers will provide gastroenterologists with timely information on individ…
Sponsor: Centro di Riferimento Oncologico - Aviano • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
AI therapist shows promise for stressed youth
Symptom relief CompletedThis randomized controlled trial aims to evaluate the effectiveness of an AI-based mental health chatbot, Emohaa, in reducing symptoms of depression, anxiety, insomnia, and academic burnout among young adults experiencing emotional distress. A total of 222 participants will be ra…
Phase: NA • Sponsor: Central University of Finance and Economics, China • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Sights, sounds, and scents: a new way to soothe ICU patients?
Symptom relief Recruiting nowThe purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit.
Phase: NA • Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New asthma drug shows promise in Mid-Stage trial
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of lif…
Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Can talk therapy beat insomnia and depression in seniors? new study aims to find out.
Symptom relief Recruiting nowThis is a multi-site randomized control trial involving people age 55+ years who have current depression symptoms plus another suicide risk indicator (either current suicidal ideation or a past history of attempt). Our goal is evaluate which of two different approaches works best…
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC